Vardar, RKarasu, ZGunsar, FAkarca, UErsoz, GBatur, Y2019-10-272019-10-2720010168-8278https://hdl.handle.net/11454/35818eninfo:eu-repo/semantics/closedAccessInterferon plus amantadine has no superiority to IFN monotherapy in naive patients with chronic hepatitis CConference Object34178178WOS:000169243400653Q1